本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.04
0.0000
盘后1.01-0.0250-2.42%18:00 EDT
成交量:3.19万
成交额:3.30万
市值:1,374.27万
市盈率:-0.95
高:1.05
开:1.05
低:1.02
收:1.04
数据加载中...
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/05/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

招股说明书

Registration statement for certain foreign private issuers
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/20

SEC问询函

[Cover]Correspondence
2019/03/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers